234 related articles for article (PubMed ID: 25120085)
1. High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction.
Ribeiro DR; Ramos AM; Vieira PL; Menti E; Bordin OL; Souza PA; Quadros AS; Portal VL
Arq Bras Cardiol; 2014 Jul; 103(1):69-75. PubMed ID: 25120085
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Predictive Roles of Risk Scores of In-Hospital Major Adverse Cardiovascular Events in Patients with Non-ST Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Aktürk E; Aşkın L; Taşolar H; Türkmen S; Kaya H
Med Princ Pract; 2018; 27(5):459-465. PubMed ID: 29672288
[TBL] [Abstract][Full Text] [Related]
4. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
6. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
Ke D; Zhong W; Fan L; Chen L
Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
[TBL] [Abstract][Full Text] [Related]
7. Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Brkovic V; Dobric M; Beleslin B; Giga V; Vukcevic V; Stojkovic S; Stankovic G; Nedeljkovic MA; Orlic D; Tomasevic M; Stepanovic J; Ostojic M
Int J Cardiovasc Imaging; 2013 Aug; 29(6):1215-28. PubMed ID: 23443340
[TBL] [Abstract][Full Text] [Related]
8. Use of TIMI Risk Index as a Simple and Valuable Prognostic Tool in Patients with ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
Çerik İB; Kaya A; Dereli S; Akkaya F; Yenerçağ M; Bektaş O
Turk Kardiyol Dern Ars; 2022 Apr; 50(3):192-201. PubMed ID: 35450843
[TBL] [Abstract][Full Text] [Related]
9. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
10. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
11. Acute coronary syndromes in octogenarians referred for invasive evaluation: treatment profile and outcomes.
Jaguszewski M; Ghadri JR; Diekmann J; Bataiosu RD; Hellermann JP; Sarcon A; Siddique A; Baumann L; Stähli BE; Lüscher TF; Maier W; Templin C
Clin Res Cardiol; 2015 Jan; 104(1):51-8. PubMed ID: 25142902
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kacprzak M; Zielinska M
Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.
Zhu H; Li Z; Xu X; Fang X; Chen T; Huang J
PeerJ; 2020; 8():e9068. PubMed ID: 32355581
[TBL] [Abstract][Full Text] [Related]
14. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
[TBL] [Abstract][Full Text] [Related]
16. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A
Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of dedicated risk scores in patients undergoing primary percutaneous coronary intervention in daily clinical practice.
Abelin AP; David RB; Gottschall CA; Quadros AS
Can J Cardiol; 2014 Jan; 30(1):125-31. PubMed ID: 24238848
[TBL] [Abstract][Full Text] [Related]
20. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
Yip HK; Hang CL; Fang CY; Hsieh YK; Yang CH; Hung WC; Wu CJ
Chest; 2005 Mar; 127(3):803-8. PubMed ID: 15764760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
